{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:12:27Z","timestamp":1792123947101,"version":"4.4.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of the People's Republic of China","doi-asserted-by":"publisher","award":["ZYYCXTD-D-202004"],"award-info":[{"award-number":["ZYYCXTD-D-202004"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2023-I2M-3\\u2013009"],"award-info":[{"award-number":["2023-I2M-3\\u2013009"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173846"],"award-info":[{"award-number":["82173846"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972632"],"award-info":[{"award-number":["81972632"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373160"],"award-info":[{"award-number":["82373160"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82322073"],"award-info":[{"award-number":["82322073"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012600","name":"ShanghaiTech University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012600","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.canlet.2025.217803","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T11:44:02Z","timestamp":1747309442000},"page":"217803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["MLCK inhibition induces synthetic lethality in MYC-driven cancer"],"prefix":"10.1016","volume":"625","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6243-3575","authenticated-orcid":false,"given":"Zhe","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiezhu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.217803_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene - the grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217803_bib2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41568-021-00367-9","article-title":"MYC protein interactors in gene transcription and cancer","volume":"21","author":"Lourenco","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2025.217803_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.167.2.353","article-title":"The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells","volume":"167","author":"Harris","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2025.217803_bib4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0092-8674(86)90280-1","article-title":"Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development","volume":"45","author":"Leder","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217803_bib5","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0092-8674(84)90257-5","article-title":"Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV\/myc fusion genes","volume":"38","author":"Stewart","year":"1984","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217803_bib6","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nature03043","article-title":"MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer","volume":"431","author":"Shachaf","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217803_bib7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature05674","article-title":"Myc deletion rescues Apc deficiency in the small intestine","volume":"446","author":"Sansom","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217803_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103756","article-title":"Therapeutic targeting of \"undruggable\" MYC","volume":"75","author":"Llombart","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.canlet.2025.217803_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41392-021-00500-y","article-title":"Alternative approaches to target Myc for cancer treatment","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2025.217803_bib10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tips.2020.11.014","article-title":"Capitalizing on synthetic lethality of MYC to treat cancer in the digital age","volume":"42","author":"Thng","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2025.217803_bib11","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1535-6108(04)00113-8","article-title":"Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway","volume":"5","author":"Wang","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217803_bib12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nm1606","article-title":"Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC","volume":"13","author":"Goga","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2025.217803_bib13","doi-asserted-by":"crossref","first-page":"13836","DOI":"10.1073\/pnas.1008366107","article-title":"Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2025.217803_bib14","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1158\/0008-5472.CAN-21-1707","article-title":"Combined inactivation of CTPS1 and ATR is synthetically lethal to MYC-overexpressing cancer cells","volume":"82","author":"Sun","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217803_bib15","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.cell.2014.03.052","article-title":"Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer","volume":"157","author":"Cunningham","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217803_bib16","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/nsmb.2189","article-title":"Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors","volume":"18","author":"Murga","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.canlet.2025.217803_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1126\/science.1212728","article-title":"A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis","volume":"335","author":"Kessler","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.canlet.2025.217803_bib18","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.1121119109","article-title":"Functional genomics identifies therapeutic targets for MYC-driven cancer","volume":"109","author":"Toyoshima","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2025.217803_bib19","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nature10927","article-title":"Deregulated MYC expression induces dependence upon AMPK-related kinase 5","volume":"483","author":"Liu","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217803_bib20","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/nm.4213","article-title":"PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression","volume":"22","author":"Horiuchi","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2025.217803_bib21","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.ccell.2022.10.009","article-title":"Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma","volume":"40","author":"Gwynne","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217803_bib22","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41467-024-45128-y","article-title":"Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinoma","volume":"15","author":"Deutzmann","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217803_bib23","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1158\/0008-5472.CAN-22-2948","article-title":"Topoisomerase 1 inhibition in MYC-driven cancer promotes aberrant R-loop accumulation to induce synthetic lethality","volume":"83","author":"Lin","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217803_bib24","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1038\/s41467-024-46572-6","article-title":"Therapeutic targeting nudix hydrolase 1 creates a MYC-driven metabolic vulnerability","volume":"15","author":"Ye","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217803_bib25","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41573-021-00252-y","article-title":"Trends in kinase drug discovery: targets, indications and inhibitor design","volume":"20","author":"Attwood","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2025.217803_bib26","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nprot.2017.016","article-title":"Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening","volume":"12","author":"Joung","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.canlet.2025.217803_bib27","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s13059-014-0554-4","article-title":"MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens","volume":"15","author":"Li","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.canlet.2025.217803_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jgg.2018.11.006","article-title":"mTOR-S6K1 pathway mediates cytoophidium assembly","volume":"46","author":"Sun","year":"2019","journal-title":"J. Genet. Genomics"},{"key":"10.1016\/j.canlet.2025.217803_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","article-title":"Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer","volume":"26","author":"Yao","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2025.217803_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-scale CRISPR-Cas9 knockout screening in human cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.canlet.2025.217803_bib31","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.cell.2014.10.024","article-title":"CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer","volume":"159","author":"Chipumuro","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217803_bib32","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/leu.2015.10","article-title":"CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo","volume":"29","author":"Gregory","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2025.217803_bib33","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1158\/0008-5472.CAN-12-2669","article-title":"Combination therapy targeting the Chk1 and Wee1 kinases shows therapeutic efficacy in neuroblastoma","volume":"73","author":"Russell","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217803_bib34","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1242\/jcs.02926","article-title":"Myosin light chain kinase plays a role in the regulation of epithelial cell survival","volume":"119","author":"Connell","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.canlet.2025.217803_bib35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/sj.embor.7400048","article-title":"D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a","volume":"5","author":"Rena","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.canlet.2025.217803_bib36","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10456-010-9183-z","article-title":"The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis","volume":"13","author":"Martiny-Baron","year":"2010","journal-title":"Angiogenesis"},{"key":"10.1016\/j.canlet.2025.217803_bib37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1432-0436.1984.tb01361.x","article-title":"Induction of squamous differentiation of normal human bronchial epithelial cells by small amounts of serum","volume":"25","author":"Lechner","year":"1984","journal-title":"Differentiation"},{"key":"10.1016\/j.canlet.2025.217803_bib38","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/BF02796396","article-title":"Clonal growth of normal adult human bronchial epithelial cells in a serum-free medium","volume":"18","author":"Lechner","year":"1982","journal-title":"In Vitro"},{"key":"10.1016\/j.canlet.2025.217803_bib39","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014407","article-title":"MYC and the control of apoptosis","volume":"4","author":"McMahon","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.canlet.2025.217803_bib40","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/304596a0","article-title":"Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes","volume":"304","author":"Land","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217803_bib41","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1158\/0008-5472.CAN-20-0787","article-title":"The myc and ras partnership in cancer: indistinguishable Alliance or contextual relationship?","volume":"80","author":"Mahauad-Fernandez","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217803_bib42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.onc.1203232","article-title":"Ras\/MEK signaling suppresses Myc-dependent apoptosis in cells transformed by c-myc and activated ras","volume":"19","author":"Tsuneoka","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217803_bib43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1101\/gad.828901","article-title":"Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells","volume":"15","author":"Elenbaas","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2025.217803_bib44","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/22780","article-title":"Creation of human tumour cells with defined genetic elements","volume":"400","author":"Hahn","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217803_bib45","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1128\/MCB.22.7.2111-2123.2002","article-title":"Enumeration of the simian virus 40 early region elements necessary for human cell transformation","volume":"22","author":"Hahn","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217803_bib46","article-title":"Targeting both the enzymatic and non-enzymatic functions of DHODH as a therapeutic vulnerability in c-Myc-driven cancer","volume":"44","author":"Zhang","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2025.217803_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10620-012-2304-3","article-title":"Myosin light chain kinase inhibitor inhibits dextran sulfate sodium-induced colitis in mice","volume":"58","author":"Liu","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.canlet.2025.217803_bib48","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/ecco-jcc\/jjz188","article-title":"Prescription Opioids induce gut dysbiosis and exacerbate colitis in a murine model of inflammatory bowel disease","volume":"14","author":"Sharma","year":"2020","journal-title":"J. Crohns. Colitis"},{"key":"10.1016\/j.canlet.2025.217803_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2020.100921","article-title":"A method to establish a c-Myc transgenic mouse model of hepatocellular carcinoma","volume":"7","author":"Mei","year":"2020","journal-title":"MethodsX"},{"key":"10.1016\/j.canlet.2025.217803_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112704","article-title":"Loss of Mettl3 enhances liver tumorigenesis by inducing hepatocyte dedifferentiation and hyperproliferation","volume":"42","author":"Wei","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2025.217803_bib51","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nrd2662","article-title":"Targeting apoptosis: selected anticancer strategies","volume":"7","author":"Storey","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2025.217803_bib52","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1074\/jbc.M209549200","article-title":"Expression of dominant-negative Fas-associated death domain blocks human keratinocyte apoptosis and vesication induced by sulfur mustard","volume":"278","author":"Rosenthal","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217803_bib53","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","article-title":"Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins","volume":"20","author":"Singh","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217803_bib54","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/cdd.2017.169","article-title":"How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?","volume":"25","author":"Aubrey","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2025.217803_bib55","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41573-022-00571-8","article-title":"Drugging p53 in cancer: one protein, many targets","volume":"22","author":"Hassin","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2025.217803_bib56","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","article-title":"Apoptosis: a link between cancer genetics and chemotherapy","volume":"108","author":"Johnstone","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217803_bib57","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S1097-2765(03)00050-9","article-title":"p53 has a direct apoptogenic role at the mitochondria","volume":"11","author":"Mihara","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2025.217803_bib58","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1535-6108(03)00272-1","article-title":"Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription","volume":"4","author":"Chipuk","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217803_bib59","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41580-019-0110-x","article-title":"The multiple mechanisms that regulate p53 activity and cell fate","volume":"20","author":"Hafner","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217803_bib60","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/oxfordjournals.jbchem.a122717","article-title":"Butanedione monoxime suppresses contraction and ATPase activity of rabbit skeletal muscle","volume":"105","author":"Higuchi","year":"1989","journal-title":"J. Biochem."},{"key":"10.1016\/j.canlet.2025.217803_bib61","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1126\/science.1081412","article-title":"Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor","volume":"299","author":"Straight","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.canlet.2025.217803_bib62","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/s41556-020-00605-6","article-title":"Nuclear F-actin counteracts nuclear deformation and promotes fork repair during replication stress","volume":"22","author":"Lamm","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217803_bib63","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncb2897","article-title":"Causes and consequences of replication stress","volume":"16","author":"Zeman","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217803_bib64","doi-asserted-by":"crossref","first-page":"18782","DOI":"10.1073\/pnas.0810199105","article-title":"Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction","volume":"105","author":"Wise","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2025.217803_bib65","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1158\/0008-5472.CAN-19-3971","article-title":"Inhibition of the MYC-regulated glutaminase metabolic Axis is an effective synthetic lethal approach for treating chemoresistant ovarian cancers","volume":"80","author":"Shen","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217803_bib66","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1083\/jcb.200703099","article-title":"Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells","volume":"178","author":"Yuneva","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217803_bib67","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.molmed.2006.07.007","article-title":"DNA damage-induced cell death by apoptosis","volume":"12","author":"Roos","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.canlet.2025.217803_bib68","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1126\/science.adh7950","article-title":"DNA damage induces p53-independent apoptosis through ribosome stalling","volume":"384","author":"Boon","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.canlet.2025.217803_bib69","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10495-022-01780-7","article-title":"BCL-2 protein family: attractive targets for cancer therapy","volume":"28","author":"Kaloni","year":"2023","journal-title":"Apoptosis"},{"key":"10.1016\/j.canlet.2025.217803_bib70","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41568-021-00407-4","article-title":"The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs","volume":"22","author":"Diepstraten","year":"2022","journal-title":"Nat. Rev. Cancer"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525003702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525003702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T20:34:26Z","timestamp":1762288466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525003702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":70,"alternative-id":["S0304383525003702"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217803","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MLCK inhibition induces synthetic lethality in MYC-driven cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217803","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217803"}}